Who We Are

Global Health

Back

Our Global Health division seeks innovative, ambitious, and scalable solutions to address health problems that have a major impact in developing countries. Learn more about the advisory committee.

Trevor Mundel

President

Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.

Emilio Emini

Director

Emilio A. Emini, Ph.D. leads the team focused on accelerating the reduction in the incidence of HIV infection, in high-burden geographies/populations of Southern and Eastern Africa.

William Foege

Senior Fellow

Dr. William Foege advises the foundation on strategies that could be usefully pursued in global health.

Dan Hartman

Director

Dr. Dan Hartman leads a team that provides technical expertise in product development and is interim director for the Malaria team.

Penny Heaton

Director

Dr. Penny Heaton leads vaccine development activities from clinical development through manufacturing and registration.

Toni Hoover

Director

Dr. Toni Hoover works on strategic planning and organizational development to advance the foundation’s principles.

Gilla Kaplan

Director

Gilla Kaplan, director, Tuberculosis, leads the team that works to accelerate the reduction of TB incidence globally.

Chris Karp

Director

Chris Karp leads the team that targets fundamental scientific and technological advances in global health to create and improve preventive and therapeutic interventions for infectious diseases.

Keith Klugman

Director

Keith Klugman, director for pneumonia, leads the foundation’s work to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools.

Andrin Oswald

Director

Dr. Andrin Oswald is the director of Life Sciences Partnerships, overseeing the foundation’s engagements with corporations.

Katey Einterz Owen

Director

Dr. Katey Einterz Owen has end-to-end responsibility for the investment portfolio in controlling, eliminating, and eradicating the diseases of the London Declaration.

Mike Poole

Director

Mike Poole is responsible for coordinating and evaluating new investment opportunities in R&D technologies, and oversees Global Health leadership engagements and strategic operations.

Dan Wattendorf

Director

Dan Wattendorf leads efforts to identify and create biotechnology platforms that result in new options for global health.

Anita Zaidi

Director

Anita Zaidi leads the work focused on vaccine development, surveillance and significantly reducing the adverse consequences of diarrheal and enteric infections.

Jennifer Weisman

Chief of Staff

Jennifer Weisman serves as an extension of the president, Global Health and drives the prioritization, communication, and execution of Global Health objectives.

Scientific Advisory Committee

Our Global Health Program advisory committee is comprised of a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group plays an important role in strengthening our work by offering independent assessments of our strategies and helping us evaluate results.

Visit Our Blog